Impact of Insulin (I.)Glargine Compared to NPH I. and to I. Detemir in Combination With Metformin on Prandial beta-cell Function and Overall Metabolic Control in Type 2 Diabetic Patients With Insufficient Metabolic Control During OAD Treatment.
Phase of Trial: Phase IV
Latest Information Update: 10 Oct 2013
At a glance
- Drugs Insulin glargine (Primary) ; Insulin detemir; Insulin suspension isophane
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 28 Apr 2012 New source identified and integrated ( EudraCT2007-006109-26: European Clinical Trials Database).
- 25 Jul 2009 New trial record